eGFR (Creatinine + Cystatin C)

Standard kidney testing relies on creatinine alone, but that number gets distorted by muscle mass, diet, and physical activity. If you are very lean, very muscular, an athlete, an older adult, or simply someone whose routine labs do not quite add up, your creatinine-only number can either overstate or understate your real kidney function. This test fixes that by combining creatinine with a second marker, cystatin C, that is far less influenced by those factors.

Knowing your true filtration rate matters because low kidney function quietly tracks higher risk of kidney failure, heart disease, stroke, hospitalization, and death long before anything hurts. The combined equation gives you the sharpest read available without doing a specialty test in a hospital setting.

What This Number Actually Tells You

eGFRcr-cys (estimated glomerular filtration rate from creatinine plus cystatin C) is not a molecule. It is a calculation that combines two blood markers to estimate how many milliliters of blood your kidneys clean each minute, scaled to a standard body size. Creatinine is a byproduct of muscle breakdown. Cystatin C is a small protein (about 13 kilodaltons) made by every nucleated cell in your body, filtered out at the kidney's filtering units (called glomeruli), and then broken down in the tubules. Because each marker has different non-kidney factors influencing it, blending them cancels out a lot of noise.

In the original validation study, the combined equation produced estimates within 30 percent of the true (measured) filtration rate in over 91 percent of cases. Only 8.5 percent of estimates fell more than 30 percent off, compared with 12.8 percent for creatinine alone and 14.1 percent for cystatin C alone. In real-world Swedish routine care, the combined equation hit roughly 90 percent accuracy and outperformed single-marker equations, including in patients with liver disease, cancer, and heart failure.

Heart Disease and Cardiovascular Risk

Lower filtration translates almost directly into higher cardiovascular risk. In an individual-participant meta-analysis of more than 27 million people across 114 cohorts, lower eGFR (whether from creatinine alone or the combined equation) and higher urine albumin were each tied to higher rates of cardiovascular death, heart failure, and atrial fibrillation. The associations were stronger and more linear when cystatin C was included.

Why the linearity matters: with creatinine alone, the relationship between eGFR and risk takes a U-shape. Risk rises both when eGFRcr drops to lower levels and when it climbs to unusually high levels, but the high-end risk usually reflects low muscle mass rather than super-healthy kidneys. The combined equation gives you a cleaner, more biologically real curve. In a Thai cohort of high-cardiovascular-risk adults, people with progressively lower kidney function (measured by creatinine-based eGFR) had stepwise higher risk of major cardiovascular events, climbing to several times the risk in the lowest filtration group versus the highest, after adjusting for standard risk factors.

Chronic Kidney Disease and Kidney Failure

One of the most important real-world uses of this test is confirming or ruling out chronic kidney disease (CKD) when your creatinine eGFR lands in the borderline zone. Research using the combined equation has shown that a meaningful share of people with borderline creatinine-based estimates are reclassified to a higher filtration tier when cystatin C is added, meaning their actual filtration is in a healthier range than a creatinine-only test suggested.

On the other side, a lower cystatin C-based estimate compared with creatinine identifies a population at much higher risk. In one large analysis, people whose cystatin C-based estimate was substantially lower than their creatinine-based estimate had about 86 percent higher mortality risk and substantially higher risk of progression to kidney failure. The combined equation captures both signals in one number.

All-Cause Mortality

Across general-population meta-analysis, mortality risk begins rising noticeably as eGFR drops into the lower filtration tiers and roughly doubles in the moderately reduced range compared with the reference range. In older adults specifically, the combined equation showed stronger and more graded associations with death than creatinine alone, catching real risk that creatinine misses.

Risk Comparisons Across Major Studies

What this means for you: a single eGFRcr-cys reading in the borderline range is a stronger forecast of long-term health outcomes than a single creatinine eGFR. If your value lands in a reduced range, that signal deserves attention, not anxiety, but action.

When the Two Markers Disagree

A meaningful share of the time, the creatinine-based and cystatin C-based estimates do not match closely. When they disagree, the combined equation is consistently more accurate than either one alone. A big mismatch, where cystatin C suggests worse kidney function than creatinine, often signals low muscle mass, chronic inflammation, or poorer overall health, all of which carry independent risk. A mismatch in the opposite direction may reflect athletes, high meat intake, or other non-kidney influences on creatinine.

This is the practical reason the combined test exists: it gives you a single, balanced answer instead of forcing you to choose between two markers that may point in different directions.

Reconciling Why High eGFR Can Still Be Risky

If you see a creatinine-only eGFR at the very top of the range and your other labs look fine, you might assume you have stellar kidneys. The data complicate that. An unusually high creatinine eGFR can reflect low muscle generating less creatinine, not unusually high filtration. The combined equation usually corrects for this. So an apparently "high" reading on creatinine alone, especially in an older or frail person, is not necessarily a good sign. eGFRcr-cys is the better arbiter.

Why One Reading Is Not Enough

The reference change value for eGFR, which captures both day-to-day biological and analytical variation, runs roughly 13 to 20 percent. That means a single reading can shift by that much without any real change in your kidneys. A baseline, followed by a repeat in 3 to 6 months, gives you a far more reliable picture than any one snapshot. If you are making lifestyle changes, starting a new medication, or have a borderline result, retest in 3 to 6 months. Otherwise, annual testing is the floor for anyone actively managing their health, and twice yearly is reasonable if you have diabetes, high blood pressure, cardiovascular disease, or a family history of kidney problems.

Trend matters more than any single number. A stable reading over five years is a completely different story than one that has dropped meaningfully in the same period, even if the latest value is the same.

When Results Can Be Misleading

• Recent heavy meat intake: boosts creatinine for hours without changing real kidney function. Cystatin C is unaffected by meat, so the combined estimate is less distorted than creatinine alone, but a high-protein meal the night before can still tilt the result.
• Acute illness, surgery, or hospitalization in the past 1 to 3 days: can shift both markers through inflammation, fluid changes, and catabolism. Wait until you are back to baseline before reading too much into a single number.
• Glucocorticoids (like prednisone or dexamethasone): can push the two markers in opposite directions. They raise cystatin C (lowering eGFRcys) independent of true filtration, and with chronic use can cause muscle loss that lowers creatinine (raising eGFRcr). Acute use can also transiently raise creatinine through protein catabolism, so the net effect depends on dose and duration. If you are on steroids, the result may not reflect your true filtration rate.
• Dolutegravir-based HIV therapy: can drop creatinine eGFR without truly worsening kidney function, because the drug blocks tubular secretion of creatinine. The size of the drop varies across studies, from a few mL/min/1.73 m² up to roughly 20 percent in some cohorts. The cystatin C component of the combined equation helps correct for this, but the result still warrants careful interpretation.

What to Do With an Unexpected Result

If your eGFRcr-cys comes back in a reduced range, the first step is to confirm with a repeat test in a few weeks, ideally after avoiding heavy meat intake and intense exercise the day before. Pair it with a urine albumin-to-creatinine ratio (UACR) to look at kidney damage separately from filtration. The two together carry far more prognostic weight than either alone. If both are abnormal, that combination warrants a conversation with a nephrologist or your primary clinician about workup for diabetes, hypertension, cardiovascular risk, and medication review.

If your creatinine-only eGFR and combined eGFR differ by a large margin, that gap itself is informative. It can signal muscle loss, inflammation, or another non-kidney process worth investigating. In high-stakes situations like drug dosing, transplant evaluation, or chemotherapy planning, that mismatch is a cue to consider a direct measured GFR using an exogenous tracer like iohexol, rather than relying on either estimate.